tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX
Australian Market

Telix Pharmaceuticals (TLX) Income Statement

Compare
493 Followers

Telix Pharmaceuticals Income Statement

Last quarter (Q2 2025), Telix Pharmaceuticals's total revenue was AU$593.11M, an increase of 168.58% from the same quarter last year. In Q2, Telix Pharmaceuticals's net income was AU$-3.48M. See Telix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60MAU$ 5.21M
Gross Profit
AU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77MAU$ -16.88M
Operating Expenses
AU$ 427.55MAU$ 263.27MAU$ 102.52MAU$ 51.48MAU$ 47.56M
Depreciation and Amortization
AU$ 5.69MAU$ 6.74MAU$ 5.38MAU$ 5.17MAU$ 4.88M
EBITDA
AU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -54.20M
Operating Income
AU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25M
Other Income/Expenses
AU$ -26.07MAU$ 0.00AU$ -25.44MAU$ -17.79MAU$ -11.00M
Pretax Income
AU$ 56.06MAU$ 3.09MAU$ -98.62MAU$ -99.04MAU$ -60.25M
Net Income
AU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89M
Per Share Metrics
Basic EPS
AU$ 0.15AU$ 0.02AU$ -0.33AU$ -0.29AU$ -0.17
Diluted EPS
AU$ 0.14AU$ 0.02AU$ -0.33AU$ -0.29AU$ -0.17
Weighted Average Shares Outstanding
331.23M 319.18M 310.64M 282.21M 257.27M
Weighted Average Shares Outstanding (Diluted)
345.19M 323.71M 310.64M 282.21M 257.27M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History